Otros idiomas Disc Medicine, Inc.

Acciones

IRON

US2546041011

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
45,07 ^USD	+1,62 %		+2,01 %	-21,97 %

20/06	Insider de Disc Medicine compró acciones por valor de 3.000.024 dólares, según un reciente registro de la SEC	MT
17/06	DISC MEDICINE, INC. : BMO Capital mantiene una recomendación de compra.	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing	20/06
Disc Medicine Prices $178 Million Common Stock Offering; Shares Rise	14/06
Disc Medicine Announces Underwritten Offering of Common Stock	14/06
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress	14/06
Disc Medicine, Inc. Presents Positive Clinical Data Across Portfolio At the European Hematology Association 2024 Congress	14/06
Disc Medicine to Participate in the Jefferies Global Healthcare Conference	30/05
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress	14/05
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference	13/05
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference	13/05
Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update	09/05
North American Morning Briefing : Stocks Seen -2-	02/04
Top Midday Decliners	01/04
Disc Medicine Trial of Light Sensitivity Treatment Achieves Primary Goal, But Misses Secondary Endpoint; Wedbush Cuts Price Target -- Shares Plunge	01/04
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)	01/04
Disc Medicine, Inc. Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Porphyria	01/04
Disc Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	21/03
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024	06/03
Disc Medicine Names Pamela Stephenson as Chief Commercial Officer	26/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Disc Medicine, Inc.

Acciones

IRON

US2546041011

Otros idiomas

Filtros